Resultados da pesquisa - Gheath Alatrash

Refinar resultados
  1. 1
    Rhabdomyolysis After Ingestion of “Foxy,” a Hallucinogenic Tryptamine Derivative

    Rhabdomyolysis After Ingestion of “Foxy,” a Hallucinogenic Tryptamine Derivative Por Gheath Alatrash, Navneet S. Majhail, James C. Pile

    Publicado em 2006
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  2. 2
    Targeting Immune Checkpoints in Hematologic Malignancies

    Targeting Immune Checkpoints in Hematologic Malignancies Por Gheath Alatrash, Naval Daver, Elizabeth A. Mittendorf

    Publicado em 2016
    Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  3. 3
    Clinical and Immunologic Effects of Subcutaneously Administered Interleukin-12 and Interferon Alfa-2b: Phase I Trial of Patients With Metastatic Renal Cell Carcinoma or Malignant Melanoma

    Clinical and Immunologic Effects of Subcutaneously Administered Interleukin-12 and Interferon Alfa-2b: Phase I Trial of Patients With Metastatic Renal Cell Carcinoma or Malignant M... Por Gheath Alatrash, Thomas E. Hutson, Luis Moltó, Amy L. Richmond, Cheryl Nemec, Tarek Mekhail, Paul Elson, Charles S. Tannenbaum, Thomas Olencki, James H. Finke, Ronald M. Bukowski

    Publicado em 2004
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  4. 4
    An anti–PR1/HLA-A2 T-cell receptor–like antibody mediates complement-dependent cytotoxicity against acute myeloid leukemia progenitor cells

    An anti–PR1/HLA-A2 T-cell receptor–like antibody mediates complement-dependent cytotoxicity against acute myeloid leukemia progenitor cells Por Анна Сергеева, Gheath Alatrash, Hong He, Kathryn Ruisaard, Sijie Lu, James N. Wygant, Bradley W. McIntyre, Qing Ma, Dan Li, Lisa S. St. John, Karen Clise-Dwyer, Jeffrey J. Molldrem

    Publicado em 2011
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  5. 5
    Breast Cancer Cell Uptake of the Inflammatory Mediator Neutrophil Elastase Triggers an Anticancer Adaptive Immune Response

    Breast Cancer Cell Uptake of the Inflammatory Mediator Neutrophil Elastase Triggers an Anticancer Adaptive Immune Response Por Elizabeth A. Mittendorf, Gheath Alatrash, Na Qiao, Yun Wu, Pariya Sukhumalchandra, Lisa S. St. John, Anne V. Philips, Haile Xiao, Mao Zhang, Kathryn Ruisaard, Karen Clise-Dwyer, Sijie Lu, Jeffrey J. Molldrem

    Publicado em 2012
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  6. 6
    Mixed T Lymphocyte Chimerism after Allogeneic Hematopoietic Transplantation Is Predictive for Relapse of Acute Myeloid Leukemia and Myelodysplastic Syndromes

    Mixed T Lymphocyte Chimerism after Allogeneic Hematopoietic Transplantation Is Predictive for Relapse of Acute Myeloid Leukemia and Myelodysplastic Syndromes Por Hans C. Lee, Rima M. Saliba, Gabriela Rondón, Julianne Chen, Yasmeen Charafeddine, L. Jeffrey Medeiros, Gheath Alatrash, Börje S. Andersson, Uday Popat, Partow Kebriaei, Stefan O. Ciurea, Betül Oran, Elizabeth J. Shpall, Richard E. Champlin

    Publicado em 2015
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  7. 7
    Results of a Randomized Phase IIb Trial of Nelipepimut-S + Trastuzumab versus Trastuzumab to Prevent Recurrences in Patients with High-Risk HER2 Low-Expressing Breast Cancer

    Results of a Randomized Phase IIb Trial of Nelipepimut-S + Trastuzumab versus Trastuzumab to Prevent Recurrences in Patients with High-Risk HER2 Low-Expressing Breast Cancer Por Guy T. Clifton, Diane F. Hale, Timothy J. Vreeland, Annelies T. Hickerson, Jennifer K. Litton, Gheath Alatrash, Rashmi K. Murthy, Na Qiao, Anne V. Philips, Jason J. Lukas, Jarrod P. Holmes, George E. Peoples, Elizabeth A. Mittendorf

    Publicado em 2020
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  8. 8
    Trastuzumab Increases HER2 Uptake and Cross-Presentation by Dendritic Cells

    Trastuzumab Increases HER2 Uptake and Cross-Presentation by Dendritic Cells Por Victor Gall, Anne V. Philips, Na Qiao, Karen Clise-Dwyer, Alexander A. Perakis, Mao Zhang, Guy T. Clifton, Pariya Sukhumalchandra, Qing Ma, Sangeetha M. Reddy, Dihua Yu, Jeffrey J. Molldrem, George E. Peoples, Gheath Alatrash, Elizabeth A. Mittendorf

    Publicado em 2017
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  9. 9
    A novel TCR-like CAR with specificity for PR1/HLA-A2 effectively targets myeloid leukemia in vitro when expressed in human adult peripheral blood and cord blood T cells

    A novel TCR-like CAR with specificity for PR1/HLA-A2 effectively targets myeloid leukemia in vitro when expressed in human adult peripheral blood and cord blood T cells Por Qing Ma, Haven R. Garber, Sijie Lu, Hong He, Eran Tallis, Xiaoling Ding, Анна Сергеева, Michael S. Wood, Gianpietro Dotti, Barbara Salvado, Kathryn Ruisaard, Karen Clise-Dwyer, Lisa S. St. John, Katayoun Rezvani, Gheath Alatrash, Elizabeth J. Shpall, Jeffrey J. Molldrem

    Publicado em 2016
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  10. 10
    Estrogen Receptor Mutations as Novel Targets for Immunotherapy in Metastatic Estrogen Receptor–positive Breast Cancer

    Estrogen Receptor Mutations as Novel Targets for Immunotherapy in Metastatic Estrogen Receptor–positive Breast Cancer Por Jonathan Goldberg, Na Qiao, Jennifer L. Guerriero, Brett Gross, Yagiz Meneksedag, Yoshimi F. Lu, Anne V. Philips, Tasnim Rahman, Funda Meric‐Bernstam, Jason Roszik, Ken Chen, Rinath Jeselsohn, Sara M. Tolaney, George E. Peoples, Gheath Alatrash, Elizabeth A. Mittendorf

    Publicado em 2024
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  11. 11
    PR1 peptide vaccine induces specific immunity with clinical responses in myeloid malignancies

    PR1 peptide vaccine induces specific immunity with clinical responses in myeloid malignancies Por M. Qazilbash, Eric Wieder, Peter F. Thall, X. Wang, Raquel Ríos, Shan Lu, Shubham Kanodia, Kathryn Ruisaard, Sergio Giralt, Elihu H. Estey, Jorge E. Cortés, Krishna V. Komanduri, Karen Clise-Dwyer, Gheath Alatrash, Qing Ma, Richard E. Champlin, Jeffrey J. Molldrem

    Publicado em 2016
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  12. 12
    PD-L1 Expression in Triple-Negative Breast Cancer

    PD-L1 Expression in Triple-Negative Breast Cancer Por Elizabeth A. Mittendorf, Anne V. Philips, Funda Meric‐Bernstam, Na Qiao, Yun Wu, Susan M. Harrington, Xiaoping Su, Ying Wang, Ana M. González-Angulo, Argun Akçakanat, Akhil Chawla, Michael A. Curran, Patrick Hwu, Padmanee Sharma, Jennifer K. Litton, Jeffrey J. Molldrem, Gheath Alatrash

    Publicado em 2014
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  13. 13
    Myeloablative Reduced-Toxicity i.v. Busulfan-Fludarabine and Allogeneic Hematopoietic Stem Cell Transplant for Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome in the Sixth through Eighth Decades of Life

    Myeloablative Reduced-Toxicity i.v. Busulfan-Fludarabine and Allogeneic Hematopoietic Stem Cell Transplant for Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome in t... Por Gheath Alatrash, Marcos de Lima, Nelson Hamerschlak, Matteo Pelosini, Xuemei Wang, Lianchun Xiao, Fábio R. Kerbauy, Alexandre Chiattone, Gabriela Rondón, Muzaffar H. Qazilbash, Sergio Giralt, Leandro de Pádua Silva, Chitra Hosing, Partow Kebriaei, Weiqing Zhang, Yago Nieto, Rima M. Saliba, Richard E. Champlin, Börje S. Andersson

    Publicado em 2011
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  14. 14
    Prognostic factors influencing survival after allogeneic transplantation for AML/MDS patients with TP53 mutations

    Prognostic factors influencing survival after allogeneic transplantation for AML/MDS patients with TP53 mutations Por Stefan O. Ciurea, Abhishek Chilkulwar, Rima M. Saliba, Julianne Chen, Gabriela Rondón, Keyur P. Patel, Haitham Khogeer, Abdul Rashid Shah, Brion Randolph, Jorge M. Ramos Perez, Uday Popat, Chitra Hosing, Qaiser Bashir, Rohtesh S. Mehta, Gheath Alatrash, Jin Im, Issa F. Khouri, Partow Kebriaei, Richard E. Champlin

    Publicado em 2018
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  15. 15
    Phase II Trial of Nelipepimut-S Peptide Vaccine in Women with Ductal Carcinoma <i>In Situ</i>

    Phase II Trial of Nelipepimut-S Peptide Vaccine in Women with Ductal Carcinoma <i>In Situ</i> Por Anne E. O’Shea, Guy T. Clifton, Na Qiao, Brandy M. Heckman‐Stoddard, Małgorzata Wójtowicz, Eileen Dimond, Isabelle Bedrosian, Diane Weber, Judy E. Garber, Alexander Husband, Ricardo Pastorello, J. Jack Lee, Mike Hernández, Diane D. Liu, Lana A. Vornik, Powel H. Brown, Gheath Alatrash, George E. Peoples, Elizabeth A. Mittendorf

    Publicado em 2023
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  16. 16
    Posttransplantation cyclophosphamide improves transplantation outcomes in patients with AML/MDS who are treated with checkpoint inhibitors

    Posttransplantation cyclophosphamide improves transplantation outcomes in patients with AML/MDS who are treated with checkpoint inhibitors Por Betül Oran, Guillermo Garcia‐Manero, Rima M. Saliba, Mansour Alfayez, Gheath Alatrash, Stefan O. Ciurea, Elias Jabbour, Rohtesh S. Mehta, Uday Popat, Farhad Ravandi, Amin M. Alousi, Tapan M. Kadia, Marina Konopleva, Courtney D. DiNardo, Katy Rezvani, Elizabeth J. Shpall, Padmanee Sharma, Hagop M. Kantarjian, Richard E. Champlin, Naval Daver

    Publicado em 2020
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  17. 17
    Immunological biomarkers of response and resistance to treatment with cabozantinib and nivolumab in recurrent endometrial cancer

    Immunological biomarkers of response and resistance to treatment with cabozantinib and nivolumab in recurrent endometrial cancer Por Vladimir Roudko, Diane M. Del Valle, Emir Radkevich, Geoff Kelly, Hui Xie, Manishkumar Patel, Edgar Gonzalez‐Kozlova, Kevin Tuballes, Howard Streicher, Swati Atale, Lisa Wang, Benito CzinCzin, Seunghee Kim‐Schulze, Ignacio I. Wistuba, Cara Haymaker, Gheath Alatrash, Ganiraju C. Manyam, Jianjun Zhang, Ryan C. Thompson, Mayte Suárez‐Fariñas, Stéphanie Lheureux, Sacha Gnjatic

    Publicado em 2025
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  18. 18
    AML-induced osteogenic differentiation in mesenchymal stromal cells supports leukemia growth

    AML-induced osteogenic differentiation in mesenchymal stromal cells supports leukemia growth Por Venkata Lokesh Battula, Phuong M. Le, Jeffrey Sun, Khoa Nguyen, Bin Yuan, Ximin Zhou, Sonali Sonnylal, Teresa McQueen, Vivian Ruvolo, Keith A. Michel, Xiaoyang Ling, Rodrigo Jácamo, Elizabeth J. Shpall, Zhiqiang Wang, Arvind Rao, Gheath Alatrash, Marina Konopleva, R. Eric Davis, Melvyn A. Harrington, Catherine W. Cahill, Carlos E. Bueso‐Ramos, Michael Andreeff

    Publicado em 2017
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  19. 19
    Haploidentical versus Matched Unrelated versus Matched Sibling Donor Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide

    Haploidentical versus Matched Unrelated versus Matched Sibling Donor Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide Por Rohtesh S. Mehta, Rima M. Saliba, Sassine Ghanem, Amin M. Alousi, Gabriela Rondón, Paolo Anderlini, Gheath Alatrash, Qaiser Bashir, Chitra Hosing, Jin S. Im, Partow Kebriaei, Issa F. Khouri, David Marín, Yago Nieto, Amanda Olson, Betül Oran, Uday Popat, Muzaffar H. Qazilbash, Jeremy Ramdial, Neeraj Saini, Samer A. Srour, Richard E. Champlin, Katayoun Rezvani, Elizabeth J. Shpall

    Publicado em 2022
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  20. 20
    Immunotherapy targeting a leader sequence cathepsin G-derived peptide

    Immunotherapy targeting a leader sequence cathepsin G-derived peptide Por Chunhua Shi, Ze Tian, Jun Yan, Mao Zhang, Pariya Sukhumalchandra, Edward Yi Chang, Guojun Yang, Junping You, Meng Cui, Qing Shi, Céline Kerros, Anne V. Philips, Na Qiao, Hiroki Torikai, Sathvik Patchametla, Анна Сергеева, Lisa S. St. John, Helen He, Dmitri Wiederschain, Benjamin H. Lee, Geraldine L. C. Paulus, Dongxing Zha, Jeffrey J. Molldrem, Gheath Alatrash

    Publicado em 2025
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:

Ferramentas de pesquisa: